Alexion Message Board

Appellis pegcetacoplan Beats Soliris in Phase 3 Trial

7 months ago

Hold your horses tough guy....Apellis just announced an offering after market close. Like clockwork, an offering always comes after good news, drowning out investors and hurting the company. How long before Apellis runs out of the money from those 7m shares? Can they even make it to FDA approval?

What's the Strategy in the U.S. for Neovasc's Reducer?

6 months ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Alexion Layoffs

7 months ago

Get your resumes ready folks!! Apellis Pharmaceuticals’ pegcetacoplan beat our very own Soliris in a head-to-head phase 3 trial.

It may not happen now but surely once pegcetacoplan is approved layoffs will be rampant.

Do we have until the end of the year before Apellis gets approval? No one knows???!!!

CFO Paul Clancy Leaving

11 months ago

Why is Paul leaving? Or was he asked to leave because of the terrible stock performance in the last two years?